Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Qiang Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3378-2056; OpenAlex author ID A5051607146. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer. Co-author DOI 10.1186/s13046-021-01879-w↗
  2. Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway. Last author DOI 10.3389/fonc.2021.754146↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qian Shen · 1 shared paper, 2021 · strength 0.15
  2. Huiting Xu · 1 shared paper, 2021 · strength 0.15
  3. Wenjie Su · 1 shared paper, 2021 · strength 0.12
  4. Chong Yang · 1 shared paper, 2021 · strength 0.12
  5. Shikai Zhu · 1 shared paper, 2021 · strength 0.12
  6. Xin Jin · 1 shared paper, 2021 · strength 0.12
  7. Dianyun Ren · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.